The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125833401 12583340 1 I 20160714 20160722 20160722 EXP US-009507513-1607USA007554 MERCK 0.00 F Y 0.00000 20160722 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125833401 12583340 1 PS INTRON A INTERFERON ALFA-2B 1 UNK 103132 POWDER FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125833401 12583340 1 Mycosis fungoides

Outcome of event

Event ID CASEID OUTC COD
125833401 12583340 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125833401 12583340 Abdominal pain
125833401 12583340 Amnesia
125833401 12583340 Anaemia
125833401 12583340 Anxiety
125833401 12583340 Arthralgia
125833401 12583340 Back pain
125833401 12583340 Chest pain
125833401 12583340 Cognitive disorder
125833401 12583340 Constipation
125833401 12583340 Cough
125833401 12583340 Depression
125833401 12583340 Diarrhoea
125833401 12583340 Dizziness
125833401 12583340 Dyspnoea
125833401 12583340 Dyspnoea exertional
125833401 12583340 Dysuria
125833401 12583340 Ear congestion
125833401 12583340 Epistaxis
125833401 12583340 Fatigue
125833401 12583340 Gingival bleeding
125833401 12583340 Haematochezia
125833401 12583340 Haematuria
125833401 12583340 Headache
125833401 12583340 Increased tendency to bruise
125833401 12583340 Insomnia
125833401 12583340 Loss of consciousness
125833401 12583340 Mass
125833401 12583340 Maternal exposure during pregnancy
125833401 12583340 Melaena
125833401 12583340 Mood swings
125833401 12583340 Mouth ulceration
125833401 12583340 Muscular weakness
125833401 12583340 Myalgia
125833401 12583340 Nausea
125833401 12583340 Odynophagia
125833401 12583340 Oedema
125833401 12583340 Orthopnoea
125833401 12583340 Palpitations
125833401 12583340 Product use issue
125833401 12583340 Pruritus
125833401 12583340 Pruritus generalised
125833401 12583340 Seizure
125833401 12583340 Sensory loss
125833401 12583340 Skin ulcer
125833401 12583340 Temperature intolerance
125833401 12583340 Trichorrhexis
125833401 12583340 Vertigo
125833401 12583340 Vision blurred
125833401 12583340 Vomiting
125833401 12583340 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found